Rubicon Research Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Rubicon Research Ltd · Outcome · 05 Nov 2026, 9:33 pm
Rubicon Research Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 5,764 (+39.9% YoY | +7.9% QoQ) ■ EBITDA: 1,441 (+52.8% YoY | +11.6% QoQ) ■ EBITDA Margin (%): 25.0 (+211 bps YoY | +83 bps QoQ) ■ PAT: 905 (+68.0% YoY | +6.7% QoQ) ■ EPS (INR): 5.41 (+55.9% YoY | +6.5% QoQ)
Original exchange filing (PDF)
More announcements from Rubicon Research Ltd
- Disclosure under Regulation 30 of SEBI LODR Regulations, 2015 (SEBI Regulations) w.r.t update on the Scheme of Merger between Rubicon Research Ltd and KIA Health Tech Pvt Ltd · 14 Nov 2026
- Transcript of Earnings Call -Q2 - FY 2026-27 · 12 Nov 2026
- Audio Recording of Earnings confrence call for the Quarter ended 30th September, 2026 · 06 Nov 2026
- Monitoring Agency Report - Q2 ended September 2026 · 05 Nov 2026
- Investor Presentation for Q2 2026-27 · 05 Nov 2026
- Rubicon Research Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Grant of Stock Options under Rubicon Research LImited Stock Option Plan 2026 · 05 Nov 2026
- Outcome of USFDA Inspection of Rubicon Research Ltd Manufactiring Facility at Ambernath, India · 30 Oct 2026
